ARTICLE | Management Tracks
Winter to lead BeiGene’s European commerical ops; plus Dyne, Axcella, Prometheus and more
March 6, 2021 12:43 AM UTC
BeiGene Ltd. (NASDAQ:BGNE; HKEX:6160) hired Gerwin Winter as SVP and head of commercial for Europe. Winter was previously SVP and head of Europe at Portola Pharmaceuticals Inc. before its acquisition by Alexion Pharmaceuticals Inc. (NASDAQ:ALXN). He also served as general manager at Celgene Corp. in Germany and Bristol Myers Squibb Co. (NYSE:BMY) in Puerto Rico and the Caribbean.
Musculoskeletal disease company Dyne Therapeutics Inc. (NASDAQ:DYN) hired Wildon Farwell as CMO. Farwell was most recently VP, global head of neuromuscular diseases, medical affairs at Biogen Inc. (NASDAQ:BIIB). ...